Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong · Delayed Price · Currency is HKD 6.02
-0.28 (-4.44%)
At close: May 28, 2026
HKG:2566 Market Cap
HKG:2566 has a market cap or net worth of 1.47 billion as of May 28, 2026. Its market cap has increased by 1.93% in one year.
Market Cap
1.47B
Enterprise Value
855.62M
Revenue
1.45B
Ranking
n/a
PE Ratio
9.70
Stock Price
6.02
Market Cap Chart
Since November 28, 2024, HKG:2566's market cap has decreased from 1.88B to 1.47B, a decrease of -21.65%. That is a compound annual growth rate of -15.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 1.47B | -20.72% |
| Dec 31, 2025 | 1.86B | 14.55% |
| Dec 31, 2024 | 1.62B | -13.73% |
| Nov 28, 2024 | 1.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 1.90B |
| SinoMab BioScience | 1.80B |
| Mabpharm | 1.65B |
| Frontage Holdings | 1.56B |
| Beijing Biostar Pharmaceuticals | 1.48B |
| Cutia Therapeutics | 1.34B |
| Zhaoke Ophthalmology | 1.32B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.32B |